Evidence map›Paper›PMID 36894375›Full record

ArticleSeminars in perinatology2023

A historical perspective of investigations into the mechanisms and management of patent ductus arteriosus.

Elaine L Shelton, Jeff Reese

Abstract readEditorial
In one paragraph

Article in Seminars in perinatology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. The molecular mechanisms of cardiac development and related diseases.Signal transduction and targeted therapy · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Elaine L SheltonDepartments of Pediatrics, Pharmacology, Vanderbilt University Medical Center, Nashville, TN, 37027 USA.
Jeff ReeseDepartments of Pediatrics, Biomedical Engineering, and Cell and Developmental Biology, Vanderbilt University Medical Center, Nashville, TN, 37027 USA. Electronic address: jeff.reese@vanderbilt.edu.

Funding

Pharmacologic Contributors to Patent Ductus ArteriosusR01HL164327 · NHLBI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI REESE, JOHN JEFFREY · 2022 to 2025
$2.9M
Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus ToneR01HD099777 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DENTON, JEROD S., SHELTON, ELAINE · 2020 to 2023
$2.3M
NHLBI NIH HHS R01 HL164327NICHD NIH HHS R01 HD099777
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ductus Arteriosus, PatentHumansIndomethacinInfant, NewbornInfant, PrematureIndomethacin

Identifiers

PMID36894375
PMCPMC10161286

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.